This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This LINGO2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 393-421 amino acids from the Central region of human LINGO2.
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Expiry Date
6 months
Vilariño-Güell, Wider, Ross, Jasinska-Myga, Kachergus, Cobb, Soto-Ortolaza, Behrouz, Heckman, Diehl, Testa, Wszolek, Uitti, Jankovic, Louis, Clark, Rajput, Farrer: "LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease." in: Neurogenetics, Vol. 11, Issue 4, pp. 401-8, (2010) (PubMed).
Ferreira, Pan-Hammarström, Graham, Gateva, Fontán, Lee, Ortmann, Urcelay, Fernández-Arquero, Núñez, Jorgensen, Ludviksson, Koskinen, Haimila, Clark, Klareskog, Gregersen, Behrens, Hammarström: "Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency." in: Nature genetics, Vol. 42, Issue 9, pp. 777-80, (2010) (PubMed).
Ichikawa, Koller, Padgett, Lai, Hui, Peacock, Foroud, Econs: "Replication of previous genome-wide association studies of bone mineral density in premenopausal American women." in: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, Vol. 25, Issue 8, pp. 1821-9, (2010) (PubMed).
Target
LINGO2
(Leucine Rich Repeat and Ig Domain Containing 2 (LINGO2))